Nonlesional diffusely abnormal appearing white matter in clinically isolated syndrome: Prevalence, association with clinical and MRI features, and risk for conversion to multiple sclerosis
- PMID: 34128576
- DOI: 10.1111/jon.12900
Nonlesional diffusely abnormal appearing white matter in clinically isolated syndrome: Prevalence, association with clinical and MRI features, and risk for conversion to multiple sclerosis
Abstract
Background and purpose: While diffusely abnormal white matter (DAWM) is a nonlesional MRI abnormality identified in ∼25% of patients with multiple sclerosis (MS), it has yet to be investigated in patients at an earlier disease stage, namely clinically isolated syndrome (CIS). The goals of this study were to (1) determine the prevalence of DAWM in patients with a CIS suggestive of MS, (2) evaluate the association between DAWM and demographic, clinical, and MRI features, and (3) evaluate the prognostic significance of DAWM on conversion from CIS to MS.
Methods: One hundred and forty-two CIS participants were categorized into DAWM and non-DAWM groups at baseline and followed for up to 24 months or until MS diagnosis. The primary outcome was conversion to MS (2005 McDonald criteria) within 6 months.
Results: DAWM was present in 27.5% of participants, and was positively associated with brainstem symptom onset, receiving corticosteroids, dissemination in space, and T2 lesion volume. DAWM was associated with an increased risk of conversion to MS over 6 months after adjustment for age and disability (hazard ratio [HR] = 2.24, p = 0.004). This association remained at a trend-level after adjustment for high-risk imaging features (HR = 1.68, p = 0.10).
Conclusions: DAWM is present in a similar proportion of patients with CIS and clinically definite MS, and it is associated with increased risk of conversion to MS over 6 months.
Keywords: clinically isolated syndrome; diffusely abnormal white matter; magnetic resonance imaging; multiple sclerosis.
© 2021 American Society of Neuroimaging.
Similar articles
-
Diffusely abnormal white matter in multiple sclerosis.J Neuroimaging. 2022 Jan;32(1):5-16. doi: 10.1111/jon.12945. Epub 2021 Nov 9. J Neuroimaging. 2022. PMID: 34752664 Review.
-
T2 Relaxometry Evidence of Microstructural Changes in Diffusely Abnormal White Matter in Relapsing-Remitting Multiple Sclerosis and Clinically Isolated Syndrome: Impact on Visuomotor Performance.J Magn Reson Imaging. 2021 Oct;54(4):1077-1087. doi: 10.1002/jmri.27661. Epub 2021 May 6. J Magn Reson Imaging. 2021. PMID: 33960066
-
Automated separation of diffusely abnormal white matter from focal white matter lesions on MRI in multiple sclerosis.Neuroimage. 2020 Jun;213:116690. doi: 10.1016/j.neuroimage.2020.116690. Epub 2020 Feb 29. Neuroimage. 2020. PMID: 32119987
-
Diffusely appearing white matter in multiple sclerosis: Insights from sodium (23Na) MRI.Mult Scler Relat Disord. 2021 Apr;49:102752. doi: 10.1016/j.msard.2021.102752. Epub 2021 Jan 14. Mult Scler Relat Disord. 2021. PMID: 33486402
-
Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels.Mult Scler Relat Disord. 2022 Jan;57:103422. doi: 10.1016/j.msard.2021.103422. Epub 2021 Nov 26. Mult Scler Relat Disord. 2022. PMID: 34871858 Review.
Cited by
-
Detection of diffusely abnormal white matter in multiple sclerosis on multiparametric brain MRI using semi-supervised deep learning.Sci Rep. 2024 Jul 26;14(1):17157. doi: 10.1038/s41598-024-67722-2. Sci Rep. 2024. PMID: 39060426 Free PMC article.
-
A focus on the normal-appearing white and gray matter within the multiple sclerosis brain: a link to smoldering progression.Acta Neuropathol. 2025 Aug 10;150(1):16. doi: 10.1007/s00401-025-02923-1. Acta Neuropathol. 2025. PMID: 40783892 Free PMC article. Review.
-
From the prodromal stage of multiple sclerosis to disease prevention.Nat Rev Neurol. 2022 Sep;18(9):559-572. doi: 10.1038/s41582-022-00686-x. Epub 2022 Jul 15. Nat Rev Neurol. 2022. PMID: 35840705 Review.
References
REFERENCES
-
- Louapre C, Bodini B, Lubetzki C, Freeman L, Stankoff B. Imaging markers of multiple sclerosis prognosis. Curr Opin Neurol 2017;30:231-6.
-
- De Stefano N, Airas L, Grigoriadis N, et al. Clinical relevance of brain volume measures in multiple sclerosis. CNS Drugs 2014;28:147-56.
-
- Vertinsky AT, Li DKB, Vavasour IM, et al. Diffusely abnormal white matter, T2 burden of disease, and brain volume in relapsing-remitting multiple sclerosis. J Neuroimaging 2019;29:151-9.
-
- Zhao G, Li D, Cheng Y. MRI dirty-appearing white matter in MS (abstract). Neurology 2000;54(Suppl 3):A121.
-
- Chen SC-Y, Chung H-W, Liou M. Measurement of volumetric lesion load in multiple sclerosis: moving from normal- to dirty-appearing white matter. AJNR Am J Neuroradiol 2003;24:1929-30.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical